Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Sichuan Biokin Pharmaceutical (688506 CH)
Watchlist
18
Analysis
Health Care
•
China
Sichuan Biokin Pharmaceutical Co.,Ltd. operates as a pharmaceutical company. The Company produces children's medicine, cardiovascular drugs, anesthetics, chronic disease drugs, and more. Sichuan Biokin Pharmaceutical conducts businesses worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Sichuan Biokin Pharmaceutical
•
26 Nov 2023 07:45
STAR50 Index Rebalance: Big Impact Expected; Inclusion Up 40% in One Month
There is 1 change for the index resulting in 1-way turnover of 2.18% and 1-way trade of CNY3.07bn. The add is up 40% over the last month and there...
Brian Freitas
Follow
519 Views
Share
bearish
•
Sichuan Biokin Pharmaceutical
•
24 Sep 2023 09:42
China Healthcare Weekly (Sep.22) - Medical Device VBP, Restore Optimism on Healthcare, Biokin Pharma
National VBP of intraocular lens/sports medicine medical consumables begins.Investors will maintain optimism when understand the logic behind...
Xinyao (Criss) Wang
Follow
529 Views
Share
bearish
•
HKEX
•
19 Nov 2023 05:30
Index Rebalance & ETF Flow Recap: FRTIB, Japan, CSI300, CSI500, STAR50, WuXi XDC, Asahi
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
Brian Freitas
Follow
588 Views
Share
bullish
•
Cross Asset Strategy
•
27 Feb 2024 11:51
•
Syndicated
CX Daily: Chinese Pharma Turns to Global Deals to Cure Capital Crunch
Biotech / Cover story: Chinese pharma turns to global deals to cure capital crunch After enduring the chill of a prolonged capital winter, China’s...
Caixin Global
Follow
182 Views
Share
bullish
•
Baimtec Material
•
25 Feb 2024 10:00
STAR50 Index Rebalance: Three Changes a Side; One Surprise Change
There are 3 changes for the STAR50 in March. Estimated one-way turnover is 2.9% resulting in a 1-way trade of CNY 4.08bn with over 2.5x ADV to...
Brian Freitas
Follow
518 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.30.3
x